Spero Therapeutics, Inc. (SPRO)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Sep 04, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Cash and Short Term Investments (Annual) : 40.26M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 40.26M |
| December 31, 2024 | 52.89M |
| December 31, 2023 | 76.33M |
| December 31, 2022 | 109.11M |
| December 31, 2021 | 146.40M |
| December 31, 2020 | 126.91M |
| Date | Value |
|---|---|
| December 31, 2019 | 82.04M |
| December 31, 2018 | 115.44M |
| December 31, 2017 | 87.29M |
| December 31, 2016 | 10.32M |
| December 31, 2015 | 5.691M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Fortress Biotech, Inc. | 79.38M |
| Kura Oncology, Inc. | 667.24M |
| Legend Biotech Corp. | 948.60M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |